ReviewEcology and evolution2026
Epitranscriptomics as a Candidate Universal Modulator of Dormancy Transitions.
Review in Ecology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RNA Aptamers and Epitranscriptomics: Charting Unexplored Territories in RNA Biology.Molecular diagnosis & therapy · 2026Review
- Epitranscriptomic control of telomere maintenance.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dormancy has been widely recognized as an evolutionarily conserved strategy that enables cells and organisms to endure environmental stress, resource scarcity, or developmental arrest. While transcriptional regulation has been extensively studied in this context, increasing attention is being directed toward post-transcriptional mechanisms that allow rapid and energy-efficient control of gene expression. Among these, epitranscriptomic modifications, chemical marks added to RNA, have emerged as dynamic and reversible regulators of mRNA fate. In this perspective, it is proposed that RNA modifications can play a central role in establishing and maintaining dormancy across diverse biological systems. Evidence from plant seeds, microbial persisters, stem cells, and dormant cancer cells suggests that specific RNA marks, such as N6-methyladenosine (m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.